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ABSTRACT
The relations between minor life events, compliance, urine 
free cortisol, and blood glucose in 40 adults with 
insulin-dependent diabetes mellitus (IDDM) was examined. 
Specifically, this study explored whether naturally- 
occurring minor stressful events had disruptive effects on 
metabolic control through: a) an arousal mechanism 
mediated by cortisol, b) disruption of the individual's 
adherence to prescribed treatment, c) a combination of 
arousal and disruption of compliance, or d) a third, 
unspecified mechanism. Stress did not influence metabolic 
control, either independently or via a stress-compliance 
or stress-arousal mechanism although stress was related to 
cortisol activity. Neither the direct effects of 
cortisol nor a cortisol by stress interaction successfully 
predicted metabolic control. Moreover, stress was 
unrelated to diet or exercise compliance and no relation 
between diet or exercise compliance and metabolic control 
was found. Only insulin compliance was found to influence 
metabolic control, although the effects of insulin 
compliance were independent of a stress-compliance 
relation. Implications of the results and directions for 
further research are discussed.
INTRODUCTION
Investigation of psychological factors in diabetes 
mellitus (DM) has a long history (see Johnson, 1980 for a 
review). Although the notion of a "diabetic personality" 
is no longer tenable (Dunn & Turtle, 1981), considerable 
research continues on psychological variables influencing 
the disorder's course. In particular, researchers have 
shown stress may influence metabolic stability in 
individuals having the disease (see Goetsch, 1989 for a 
review). In addition, those factors moderating the 
influence of stress on the disease have been important.
Adults with DM provide an excellent population for 
investigating the effects of stress on the disorder. In 
addition to the stringent requirements of their treatment 
regimen, insulin-dependent DM patients have a higher 
frequency of hospital admissions and are more likely to 
experience poor metabolic control than do their non­
insulin dependent cohorts (Davis, Hess, Van Harrison, & 
Hiss, 1987). Poor metabolic control may increase the 
likelihood of developing complications associated with the 
disorder. Adults with DM are, therefore, by virtue of the 
length and nature of their illness, a population at risk 
for severe complications of their disease. Determining 
the extent to which minor stress may contribute to the 
increased risk is an area needing research.
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The purpose of this investigation was to examine the 
two primary hypothetical mechanisms regarding the effects 
of stress on metabolic control in DM. Both the direct 
effects via a sympathetically-mediated arousal mechanism 
and indirect effects via disruption of compliance 
behaviors were explored. Specifically, the relations 
between minor life events, compliance behaviors, urine 
free cortisol, and blood glucose in young adults with 
insulin-dependent diabetes mellitus (IDDM) were 
investigated.
In the ensuing literature review, an overview of DM 
will be provided, including the pathophysiology and 
treatment of the disorder followed by current etiological 
theories. In addition, a brief introduction to the 
concept of stress and its relation to illness will be 
included. Finally, a review of available literature 
regarding stress-arousal and stress-compliance hypotheses 
and their relation to metabolic stability in IDDM will be 
presented.
Definition and Impact of the Disorder
Diabetes mellitus is a group of complex disorders of 
carbohydrate metabolism associated with compromised 
insulin activity or production. The cardinal symptom of 
DM is hyperglycemia, however, polyuria, polydipsia, 
polyphagia, fatigue, weight loss, and blurred vision also 
characterize DM (Olefsky, 1988). In addition, a variety
of microvascular and macrovascular complications are 
associated with the disorder. Microvascular complications 
include thickening of the capillary basilar membranes, 
retinopathy, and nephropathy, while accelerated 
atherosclerotic development and peripheral vascular 
disease are common macrovascular complications. Other 
frequent problems include peripheral neuropathy, 
complications of pregnancy, and increased risk of 
infection (Davidson, 1981; Kahn, 1985).
The U.S. Department of Health and Human Services 
(USDHHS, 1985) estimates as many as 10 million Americans 
currently have DM. DM is the 10th leading cause of death 
in the United States (Turk & Speers, 1983) and the leading 
cause of new blindness (Davidson, 1981). Risk of stroke 
and myocardial infarction is increased 2-fold in 
individuals with DM, while risk of renal failure is 17 
times greater (Cahill, 1985? Davidson, 1981). Individuals 
with DM also are at significantly increased risk of 
developing coronary artery disease. Moreover, incidence 
of peripheral vascular disease is increased 50 times over 
non-diabetics (Cahill, 1985) contributing to the high rate 
of amputations in this population.
DM also represents a significant economic burden. In 
1980, economic costs of DM were estimated to be as high as 
$9.7 billion including costs of morbidity and mortality 
(Krall, Entmacher, & Drury, 1985). Direct costs of
medically related services were approximately $4.8 
billion, including $2.2 billion for medical care, $1.24 
billion for nursing home care, $840 million for patient 
visits to physicians, and $380 million for medication 
(Krall et al., 1985).
The World Health Organization (WHO, 1980) has 
proposed three classification categories of DM including 
Type I DM, or insulin-dependent diabetes mellitus (IDDM), 
Type II, or noninsulin-dependent diabetes mellitus 
(NIDDM), and DM associated with specific medical 
conditions (e.g., pancreatic disease, genetic syndromes, 
drug-induced conditions). The remainder of this 
discussion will focus on Type I DM, or IDDM. 
Pathophysiology of IDDM
Insulin, an anabolic hormone secreted by pancreatic 
beta cells, regulates storage and use of the body's energy 
sources. Three primary insulin-sensitive tissues are 
influenced by its action: liver, muscle, and adipose 
tissue. In the liver, insulin stimulates the storage of 
glucose as glycogen or fat. Moreover, the presence of 
active insulin controls glycogenolysis (the breakdown of 
glycogen into glucose) in a fasting state. In muscle and 
adipose tissue, insulin serves to increase cell 
permeability to glucose providing cells with a readily 
available energy source. Insulin also facilitates fat 
synthesis and inhibits breakdown of previously stored
fats. Finally, insulin influences protein metabolism by 
facilitating protein synthesis and inhibiting breakdown of 
stored protein in tissues (Davidson, 1981).
Under normal conditions, insulin secretion increases 
after one eats in response to the carbohydrate and protein 
content of a meal (Davidson, 1981). Increased circulating 
levels of insulin stimulate storage of glucose and fat as 
energy reserves in insulin-sensitive tissues. While one 
fasts, insulin levels decline. The relative lack of 
insulin during a fast (i.e., between meals and at night) 
facilitates release of stored glucagon and fatty acids as 
fuel sources (Cahill, 1985). Any disruption of the 
balance of this process serves to alter significantly the 
body's metabolism of carbohydrates, fats, and proteins.
In Type I DM, beta cells of the pancreas fail to 
produce insulin, resulting in an absolute deficiency of 
endogenous insulin. Therefore, while fasting one's 
insulin deficiency provides a continuous signal to 
insulin-sensitive tissues to release stored fuels.
Fasting blood glucose levels of individuals with Type I DM 
are, therefore, significantly elevated over normals. A 
further postprandial elevation of blood glucose also 
occurs in individuals with IDDM. Consequently, 
individuals with IDDM experience both fasting and 
postprandial hyperglycemia. Hyperglycemia is currently the
most commonly used basis for diagnosis of DM (Davidson, 
1981).
Left untreated, hyperglycemia further deteriorates in 
the absence of insulin's inhibitory effects on 
glyconeolysis and leads to water and electrolyte depletion 
(Davidson, 1981). Changes in protein metabolism caused by 
a lack of insulin results in the synthesis of additional 
glucose from amino acids as well as water and electrolyte 
imbalances.
Additional detrimental effects may be caused by 
changes in fat metabolism. Lack of available insulin 
leads to accelerated lypolysis (i.e., breakdown of 
triglycerides) and subsequent increases in glycerol and 
free fatty acids (FFA) in blood. Glycerol contributes to 
further release of glucose by the liver further 
complicating the hyperglycemic state. Moreover, FFA 
release leads to ketogenesis (i.e., the development of 
ketone bodies). Overproduction of ketone bodies can 
exceed the body's ability to neutralize acid effects and 
acidosis may ensue (Davidson, 1981).
The constellation of acidosis, ketonuria (i.e., 
ketone bodies in the urine), dehydration, and electrolyte 
depletion is known as diabetic ketoacidosis (DKA) and is 
life-threatening. DKA may be the first clinical 
indication of IDDM (Olefsky, 1988) and prior to discovery
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of insulin was the leading cause of death in persons with 
IDDM (Davidson, 1981).
Management of IDDM
Maintenance of a normoglycemia is the primary goal of 
diabetes treatment (Olefsky, 1988). Available evidence 
suggests prolonged hyperglycemic conditions may 
significantly contribute to development of microvascular 
complications and increase the likelihood of later kidney 
and eye disease (Cahill, Etzwiler, & Freinkel, 1976; 
Olefsky, 1988; Zimmerman, 1989). Hypoglycemic states, 
conversely, can quickly result in permanent damage to the 
central nervous system (Olefsky, 1988).
Presently, the principal means of attaining 
normoglycemia is through use of exogenous insulin 
injections. Most IDDM patients must administer at least 
two injections daily of some combination of short-, 
intermediate-, or long-acting insulin in an attempt to 
approximate the action of endogenous insulin. Glucose 
levels also must be monitored by the patient several times 
daily to assess glycemic control. Unfortunately, 
exogenous insulin injections are only partially successful 
in achieving normoglycemia (Cahill et al., 1976).
Insulin-infusion pumps, an alternative to self- 
administration of injections, are a more recent 
development in treatment of IDDM. Pumps provide insulin 
to the individual 24 hours a day and provide a potential
means to improve glycemic control. However, nocturnal 
hypoglycemia is a serious potential side effect of 
infusion pump use (Olefsky, 1988). In addition, pumps 
present a more visible indicator of illness and may 
require even more lifestyle changes than insulin- 
injections (Olefsky, 1988). Regardless of the method of 
insulin therapy used (i.e., injection or pump), a great 
deal of responsibility for management of the disorder 
rests with the patient (Olefsky, 1988).
In addition to insulin therapy, IDDM patients must 
adhere to stringent diets. The number of calories 
ingested and the source of the calories (i.e., fats, 
carbohydrates, etc.) must be closely monitored. A low 
level of fats in the diet and reduced ingestion of sugars 
are minimal requirements of a diabetic diet. Timing of 
meals is also important because caloric intake must be 
adjusted to correspond to available insulin activity. 
Frequent small meals are, therefore, generally prescribed 
to avoid significant post-prandial metabolic changes.
A third area of IDDM treatment involves exercise. A 
moderate physical exercise regimen is often prescribed by 
the physician as part of a total treatment program. 
Exercise may improve glucose utilization and decrease 
peripheral resistance to insulin (Ekoe, 1988). Excessive 
exercise or exercise in the presence of insufficient 
insulin, however, may result in hypoglycemia (Horton,
1988). Nonetheless, exercise is a frequent component of 
diabetes management.
Finally, patient education is an important component 
of diabetes management. The complex nature of the 
disorder and the demands placed on the patient require a 
high level of understanding of the disease. A recent 
meta-analysis of educational interventions reported 
patient education was a significant factor in positive 
patient outcome (Brown, 1988).
Etiology of IDDM
Although damage to the pancreatic beta cells in 
patients with DM was noted at the turn of the century 
(Cahill, 1985), to date the etiology of the disorder has 
eluded medical researchers. Nonetheless, scientists agree 
the disease appears to run in families and is frequently 
associated with infectious processes and abnormal 
immunological functioning. These findings have led 
researchers to suggest DM is a complex phenomenon subject 
to multiple influences (Soeldner, 1982). A brief 
literature review of the three primary areas involved in 
the etiology of IDDM follows; namely genetic, viral, and 
autoimmune contributions. The role of psychological 
factors in the etiology and course of the disease also 
will be discussed.
Genetic Influences. Three primary lines of evidence 
support a genetic role in the etiology of DM. Data from
10
twin, family, and histocompatibility antigen studies 
support a genetic contribution. However, the data are far 
from conclusive. Using more than 100 monozygotic twin 
pairs, Pyke and Nelson (1976) found 50% concordance in 
twins diagnosed with DM before age 40. Based on age at 
diagnosis, these data appear related to individuals with 
IDDM. However, in twins whose diagnoses were made after 
age 40 (suggesting a diagnosis of NIDDM), concordance 
approached 100%. Others have reported similar findings 
(Gottlieb & Root, 1968). A strong genetic component in 
NIDDM is suggested, but data are less conclusive regarding 
an etiological role of heredity in Type I DM.
No identifiable pattern of inheritance has been 
identified in patients with IDDM (Craighead, 1978) 
although it is agreed the syndrome is not autosomal 
dominant (Olefsky, 1988). Reports based on family studies 
reveal a fairly low degree of direct transmission from 
affected parents to offspring. Risk to offsprings of 
diabetic parents is estimated to be 2 to 5% compared to 
0.2 to 0.3% risk in the general population. For children 
with IDDM, sibling risk increases to 5 to 10% (Olefsky, 
1988). Significantly increased risk is accrued, however, 
if siblings are human leukocyte antigen (HLA) identical to 
the affected sibling (Olefsky, 1988).
Although no specific genetic marker for IDDM has been 
identified, researchers have expressed considerable
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interest in the increased incidence of IDDM associated 
with certain HLA antigens. The presence of the HLAs 
does not directly cause IDDM; rather specific loci of the 
major histocompatibility complex encoded on chromosome 6 
appear related to increased risk (Olefsky, 1988). HLAs 
may offer a means of identifying those individuals most 
vulnerable to IDDM and provide clues to the existence of a 
••diabetogenic" gene (Olefsky, 1988) .
The preponderance of evidence from genetic studies 
suggests IDDM is influenced by genetic factors. Yet, 
available data also indicate an equally strong influence 
of nongenetic variables. Olefsky (1988) suggests 
determination of the precise contribution of heredity is 
difficult for four primary reasons: 1) no specific marker 
has been identified, 2) the degree of heterogeneity both 
within and between types of DM (i.e., IDDM and NIDDM), 3) 
the interaction between a "diabetogenic" gene, other 
genetic factors, and environmental factors, and 4) low 
rates of transmission of the disorder from generation to 
generation. At present, the majority of investigators 
believe genetic factors are diathetic, requiring other 
influences to result in expression of the illness 
(Craighead, 1978; Olefsky, 1988) .
Viral Influences. A second area of interest in the 
etiology of IDDM involves the role of viral agents. In 
his review Olefsky (1988) outlined several lines of
evidence for a viral component in the onset of IDDM.
First, incidence of IDDM has been reported to vary on a 
seasonal basis. A number of authors report increased 
onset of DM during the late summer to early autumn or 
winter months (e.g., MacMillan, Kotoyan, Zeidner, &
Hafezi, 1977) corresponding to the presence of increased 
viral infections during these times. Second, a history of 
viral illness is frequently found to precede diagnosis of 
IDDM, particularly mumps (Sultz, Hart, Zielezny, & 
Schlesinger, 1975) and Coxsackie B virus (Gamble, Kinsley, 
FitzGerald, Bolton, & Taylor, 1969). Third, an increase 
in viral titers is often found in patients newly diagnosed 
with IDDM at or near the beginning of their illness.
A fourth line of evidence to support a viral role in 
the onset of IDDM involves the use of animal studies. 
Injections of "diabetogenic" viruses (e.g., Coxsackie B, 
encephalomyocarditis) can led to onset of IDDM in rodents. 
Moreover, the likelihood of developing IDDM after viral 
innoculation can be manipulated by varying genetic 
susceptibility to the disease. This evidence supports a 
predisposing role of heredity in IDDM that is further 
aggravated by the presence of physiological stressors 
(i.e., viral infection). Finally, "diabetogenic" viruses 
introduced to beta cells in culture medium have been shown 
to cause cell lysis and necrosis (e.g., Prince, Jensen, 
Billup, & Notkins, 1978). These findings are particularly
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indicative of a viral component to IDDM suggesting a 
direct effect of viral activity on pancreatic beta cell 
integrity.
Autoimmune Influences. A final area of concern in 
the etiology of IDDM involves autoimmune reactions. An 
automimmune process is believed to affect beta cells 
leading to their destruction (Kahn, 1985). Several lines 
of evidence support an autoimmune reaction in IDDM.
First, IDDM is frequently associated with other endocrine 
disorders of autoimmune origin (Kahn, 1985). In 
particular, disorders of the adrenal and thyroid gland 
often coexist with IDDM (Kozak & Cooppan, 1985). Because 
autoimmune disorders tend to occur more frequently in 
families of affected individuals, a genetic predisposition 
to develop autoimmune diseases may be involved (Kaldany, 
Busick, & Eisenbarth, 1985).
Second, a number of studies indicate a high level of 
islet-cell antibodies (ICA) in patients with IDDM (see 
Kaldany et al., 1985 for a review). Combined data from 
several studies indicate 29.2% of patients with IDDM had 
ICAs as compared to 1.3% of nondiabetic persons (Kaldany 
et al., 1985). Elevated levels of ICA are most commonly 
reported in recently diagnosed individuals, although some 
patients maintain high ICA titers for a number of years 
(Kaldany et al., 1985). While these results are far from 
conclusive and data exist to suggest the presence of ICAs
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alone are insufficient to account for the disorder (cf., 
(Olefsky, 1988, Kahn, 1985), increased levels of ICAs at 
or about the time of diagnosis in IDDM nonetheless 
suggests involvement of an autoimmune process. Finally, 
immunosuppressive treatment has been shown to prevent 
development of IDDM in genetically susceptible rats 
(Laupacis et al., 1983; Like, Anthony, Guberski, &
Rossini, 1983).
In summary, similar to the potential viral influences 
in the etiology of IDDM, autoimmunity appears to play a 
role in the genesis of the disease. At present, however, 
the mechanism initiating an autoimmune response is unknown 
(Kahn, 1985). The most plausible explanation of the 
etiology of IDDM, based on current data, is that an immune 
response is initiated in response to environmental factors 
(e.g., viruses or toxins). The autoimmune response, 
modulated by genetic variables, then results in beta cell 
destruction. That is, the multiple effects of genetic, 
viral, and autoimmune influences culminate in IDDM.
Influence of Psychological Factors. Throughout 
history, psychological factors have been believed to have 
a role in the etiology of DM. Thomas Willis, in the 17th 
century, believed DM was caused by prolonged sorrow 
(Johnson, 1980). More recently, Menninger (1935) 
suggested anxiety and depression were characteristic of 
the 'diabetic personality'. These theories grew largely
15
from the psychoanalytic perspective suggesting specific 
personality traits caused or led to an exacerbation of the 
disease via displacement of psychological conflicts 
(Daniels, 1939). Individuals with DM were variously 
believed to be less alert, more apathetic, more 
hypochondriacal, and more likely to become depressed than 
were non-diabetic persons (Menninger, 1935).
In a seminal review article by Dunn and Turtle 
(1981) , the concept of a specific diabetic personality 
with etiological implications for the disorder was 
seriously challenged. Investigations of specific traits 
etiologically linked to DM have been methodologically 
flawed (Dunn & Turtle, 1981) and have little empirical 
support (Dunn & Turtle, 1981; Surwit, Feinglos, & Scovern, 
1983; Turk & Speers, 1983). No consistent traits have 
been identified across individuals with DM (Surwit et al., 
1983). Thus, theories of personality factors as 
contributors to the etiology of the disease are no longer 
accepted.
Psychological factors, however, continue to be an 
important area of research. Over the course of the 
disorder researchers have found psychologically meaningful 
events (i.e., stress) may influence metabolic control of 
individuals having the disease. Investigation of the role 
of stress in DM grew largely from clinical observations of 
the frequency of stressful occurrences associated with
onset of diabetic crisis. Decompensation of diabetic 
control (i.e., DKA) may be precipitated by emotional or 
environmental stress (Olefsky, 1988). Nabarro (1965) 
found that approximately 14% of severe DKA cases were 
preceded by environmental stress. Similarly, Cohen,
Vance, Runyan, and Hurwitz (1960) reported stress related 
to onset of DKA in approximately 15% of their sample.
These findings have resulted in a large body of literature 
on the effects of stress on metabolic control. In 
addition, those factors that may moderate or mediate the 
influence of stress on the disease have been an important 
area of investigation.
STRESS AND ILLNESS
Before proceeding to a review of the pertinent 
literature involving stress effects on metabolic control 
in IDDM, a discussion of the concept of stress will be 
provided. In addition, two principal means of 
investigating the stress-disorder relation, that is, 
physiological changes associated with stress and the 
influence of life events on IDDM will be provided.
Stress, as formulated by Selye (1956), is manifested 
by a pattern of physiological responses (i.e., the General 
Adaptation Syndrome) influencing the likelihood of 
illness. According to Selye*s model, after exposure to 
demands the body responds via biochemical activity. For 
Selye, these biochemical changes defined stress.
Continued stress leads to attempts to regain homeostasis 
and counteract the physiological effects of environmental 
demands. Prolonged exposure to stressors, however, 
depletes the organism's ability to maintain a homeostatic 
state effectively. Exhaustion quickly ensues resulting in 
breakdown of the body's defensive systems, subsequent 
tissue damage, and perhaps death. Selye's model of stress 
in the pathogenesis of illness, therefore, involves 
depletion of homeostatic adaptive mechanisms secondary to 
exposure to stressors.
Selye's model provided the first systematic 
theoretical notions of potential changes in physiological
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functioning resulting from stress. Although Selye's work 
served as the impetus for much of the later research 
involving stress and illness, his theory has not stood 
without criticism (see Hamberger & Lohr, 1984 for a 
review). Nonetheless, the physiological changes 
accompanying the stress response proposed by Selye served 
as an important model for understanding the physiological 
substrates of stress.
Researchers now believe three primary biochemical 
pathways are involved in the human stress response: 1) the 
neural, 2) neuroendocrine, and 3) endocrine axes (Everly, 
1989). The body's earliest response to stressors involves 
increased autonomic activity. As a result of innervation 
of neural pathways in the spinal cord and sympathetic 
ganglia, norepinephrine (NE) is released by sympathetic 
neurons, causing generalized arousal in target end organs. 
Activity of the neuroendocrine axis involves release of 
the adrenal medullary catecholamines, NE and epinephrine 
and mimics the effects of sympathetically-mediated release 
of NE (Everly, 1989).
The final phase of the stress response involves 
activity of the endocrine system. Activity of the adreno­
cortical axis is a particularly important aspect of this 
response. Pituitary secretion of adrenocorticotropic 
hormone (ACTH) leads to stimulation of the adrenal cortex. 
In response to ACTH, the adrenal cortex secretes
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glucocorticoids and mineralocorticoids. The primary 
glucocorticoids, cortisol and corticosterone, have a 
number of systemic effects including increased glucose 
production, increased production of urea, increased 
release of free fatty acids, and suppression of immune 
responses and appetite (Everly, 1989). The 
mineralocorticoids, aldosterone and deoxycorticosterone 
are important in regulation of electrolytes and serve to 
increase blood pressure.
Much of stress research has focused on the activity 
of cortisol, the principal glucocorticoid secreted by the 
adrenal cortex. Researchers have reported significantly 
increased cortisol levels associated with a variety of 
laboratory stressors including: venipuncture stress 
(Hubert, Moller, & Nieschlag, 1989), caffeine 
administration, reaction time tasks (Lovallo et al.,
1989), mental arithmetic (Pomerleau & Pomerleau, 1990) , 
and examination stress (Meyerhoff, Oleshansky, & Mougey,
1988). Daily minor stress also has been reported to 
influence cortisol levels. Brantley, Dietz, McKnight, 
Jones, and Tulley (1988a) reported a positive relation 
between daily fluctuations in minor stressful events and 
cortisol in medical personnel.
In summary, Selye's (1956) conceptualization of 
stress as a series of specific physiological responses has 
led to investigation and further understanding of the
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autonomic and endocrine activity associated with 
environmental stressors. Research indicates that 
laboratory and relatively minor life events can influence 
the physiological parameters underlying human stress.
Drawing from Cannon's (1935) early work, another 
tradition evolved to explore the effects of stress on 
health. Cannon's (1935) investigations focused on the 
stimulus properties of physical or emotional stress in 
disrupting internal homeostatic mechanisms. In contrast 
to Selye, Cannon viewed stress as the stimulus leading to 
physiological changes. The shift in focus from the 
response of the organism as "stress" to the stimulus as 
"stress" led to the development of interest in the role of 
life events as potential mediators of the stress-illness 
relation. A great deal of research has focused on the 
role of life events in the cause or exacerbation of 
illness. The occurrence of life events now is believed to 
be a risk factor for adverse health outcome (Elliot & 
Eisdorfer, 1982).
Much of the early research on life events as a means 
of investigating the stress-disorder relation developed 
from the work of Holmes and Rahe (1967) on adjustment to 
major life events. Major life events are frequently 
associated with significant life change and include, for 
example, marriage, birth of a child, or death of a loved 
one. Using the Schedule of Recent Events (SRE) to assess
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the occurrence of major life events, respondents indicate 
which of 43 major life events occurred during the past 
year. A number of studies have reported positive 
relations between the occurrence of major life events and 
both physical and psychological symptoms (see Dohrenwend & 
Dohrenwend, 1978, 1981; Rabkin & Streuning, 1976 for 
reviews). The adjustment required by these events are 
proposed to increase significantly the likelihood of 
developing a variety of physical disorders (Rahe & Arthur, 
1978).
Although use of the SRE or modifications of the scale 
dominated behavioral medicine research on stress during 
the 1970s (Kanner, Coyne, Schaefer, & Lazarus, 1981), the 
research has not been without criticism (see Dohrenwend & 
Dohrenwend, 1978 for a review). Criticisms of the life- 
events approach have ranged from psychometric issues 
(e.g., Schroeder & Costa, 1984) to effect size (e.g., 
Rabkin & Streuning, 1976). Empirical support for the 
effect of major life events on illness, for example, has 
traditionally been quite modest (Rabkin & Streuning,
1976).
In addition, the SRE does not allow the respondent to 
indicate whether the change associated with the life event 
is positive or negative in direction. Several authors 
reported no relation between change associated with 
positive major life events (e.g., birth of a child) and
later adaptation (e.g., Ross & Minowsky, 1979; Vinokur & 
Selzer, 1975). In response to the criticisms of the SRE, 
Sarason, Johnson, and Siegel (1978) attempted to improve 
assessment of major life events through development of the 
Life Experiences Survey (LES). The LES is more carefully 
worded than the SRE and allows respondents to indicate 
whether the event was positive or negative. In addition, 
the LES provides subjects with the opportunity to indicate 
the subjective impact of the event on a Likert-type scale.
More recently, investigators interested in the 
stress-disorder relation have focused attention on effects 
of daily minor stressors or "hassles" (Brantley, Waggoner, 
Jones, & Rappaport, 1987; DeLongis, Coyne, Dakof, Folkman, 
& Lazarus, 1982; Kanner et al., 1981, Monroe, 1983).
Minor stressors include such things as getting stuck in 
traffic, performing poorly on a task, or bad weather. 
Compared to major life events, minor stressors more likely 
occur on a daily basis and generally impact the individual 
less (Brantley & Jones, 1989). Investigations of minor 
stress may offer information on the temporal relation 
between symptom onset and exacerbation not apparent when 
using more global, retrospective measures of major life 
events. In addition, minor stress contributes information 
independently of what can be attributed to major life 




Two primary hypotheses regarding effects of stress on 
IDDM have been delineated. First, stress may directly 
influence metabolism in IDDM via action of the 
counterregulatory or "stress" hormones, suggesting that 
stress' effects on metabolism are mediated by arousal, or 
activation of the sympathetic branch of the autonomic 
nervous system. In response to sympathetic arousal, 
release of hormones associated with the stress response 
(e.g., ACTH, growth hormone, corticosteroids, NE, and 
epinephrine) result in reduced plasma insulin in normal 
individuals. Consequently, levels of blood glucose and 
free fatty acids (FFA) are increased (Lustman, Carney, & 
Amado, 1981; Tarnow & Silverman, 1981-82) resulting in 
mobilization of energy sources for use in a "fight or 
flight" response. In individuals with DM, metabolic 
changes associated with stress further compromise 
metabolic stability and lead to diabetic crises.
A second theory concerning the effects of stress on 
IDDM involves the indirect effects of stress on compliance 
to diabetic regimens. Accordingly, behavioral or 
emotional disruption resulting from the presence of 
stressors interferes with effective patient self-care. 
Stress adversely influences the course of DM through its 
effects on diet, insulin injections, glucose monitoring, 
or other aspects of a diabetic regimen.
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Maintenance of normoglycemia requires adherence to a 
complex set of demands. IDDM patients must perform 
insulin injections, maintain dietary restrictions, and 
monitor blood glucose. Moreover, these behaviors must be 
performed in a temporally prescribed manner numerous times 
during the day (Glasgow, McCaul, & Schafer, 1986). As a 
result, adherence to diabetic regimens is poor typically 
(Fisher, Delameter, Bertelson, & Kirkley, 1982; Surwit et 
al., 1983; Turk & Speers, 1983).
Failure to adhere to the therapeutic regimen may 
contribute to metabolic instability (Turk & Speers, 1983). 
As previously mentioned, maintenance of metabolic 
stability is an important goal of treatment in DM. 
Moreover, a number of researchers suggest that failure to 
maintain adequate metabolic control may contribute to 
development of later complications of the disorder 
(Knuiman, Welborn, McCann, Stanton, & Constable, 1986; 
Skyler, 1979). As a result, the potential influence of 
both the direct and indirect effects of stress on 
metabolic control have generated a great deal of research.
In summary, two major hypotheses exist regarding the 
effects of stress on metabolic control in DM: a) direct 
effects via an autonomically-mediated arousal mechanism 
and b) indirect effects caused by disruption of compliance 
to prescribed regimens. The hypothesized effects of 
stress on metabolic control are graphically presented in
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Figure 1. The following discussion will provide a review 
of the stress-arousal and stress-compliance literature.
Stress and Arousal. In perhaps the most frequently 
cited study regarding the effects of stress on metabolic 
control, Kemmer et al. (1986) investigated the effects of 
stress associated with mental arithmetic and public 
speaking in nine non-diabetic, nine normoglycemic Type I 
(i.e., good metabolic control), and nine Type I adults 
with induced hyperglycemia (i.e., poor metabolic control). 
Moreover, Kemmer et al. (1986) examined the effects of 
stress on the counterregulatory hormones hypothesized to 
be causally related to poor metabolic control. This study 
was designed to directly examine arousal effects of 
stress-induction on metabolic outcome variables. Stress 
had no effect on measures of blood glucose, plasma 
ketones, FFA, GH, or glucagon in patients in either poor 
or good metabolic control. However, significant changes 
in NE, E, and cortisol were reported. These data failed 
to support an arousal-mediated stress effect on 
metabolism. The authors conclude metabolic control is not 
changed by "sudden, short-lived emotional arousal that may 
be produced by the common stressful events of daily life" 
(p 1083).
Kemmer et al. (1986) note several possible reasons
for their negative findings. First, the increases in 

















statistically significant, may have been biologically 
insufficient to cause metabolic disruption. Second, use 
of laboratory-induced stressors may not adequately 
represent hormonal or metabolic changes accompanying 
naturally-occurring stressors. Conclusions about the 
effects of stress on metabolic control are thus limited by 
the external validity of the stressors.
In a similar study, Delameter et al. (1988) reported 
significant reductions in GH, cortisol, and free insulin 
in 31 adolescent subjects after exposure to either a 
cognitive quiz or stressful family interactions. Glucagon 
levels were significantly increased, while glucose, FFA,
E, and NE were unchanged by the stressors. Similar to the 
results of Kemmer et al. (1986), the stress-arousal 
hypothesis was not supported. However, the results of 
this study are limited by use of a relatively brief stress 
period (i.e., 10 min) and failure to control statistically 
for diurnal variations in GH, cortisol, and free insulin 
levels. In addition, it may be inappropriate to compare 
the results of this study with research on adults. Chase 
and Jackson (1981) and Brand, Johnson, and Johnson (1986) 
reported age differences in the influence of stress on 
metabolic control suggesting caution should be used when 
making comparisons between investigations using different 
age groups.
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In summary, the results of studies employing a 
laboratory stress-induction paradigm are suggestive of a 
potential disruptive role for stress on metabolism. 
However, these studies (i.e., Delameter et al., 1988; 
Kemmer et al., 1986) were unable to support the stress- 
arousal hypothesis. Unfortunately, methodological 
problems may have precluded adequate evaluation of the 
arousal hypothesis.
An overriding criticism of the stress-arousal studies 
is their lack of relevance to daily life (Goetsch, 1989; 
Jacobson, 1986). Laboratory-induced stressors may differ 
significantly from naturally-occurring stressors.
Stressors employed in the laboratory are relatively 
circumscribed and short-lived. In addition, they may have 
limited meaning to research participants. In contrast, 
naturally-occurring stressors may be more prolonged or 
have greater subjective impact for the individual. 
Moreover, multiple naturally-occurring stressors may have 
a cumulative impact on the individual sufficient to result 
in metabolic disruption. The lack of generalizability to 
daily life represents a major concern regarding 
investigations utilizing a stress-induction paradigm.
Stress and Compliance. In response to the 
methodological limitations associated with laboratory- 
induced stressors, other investigations have focused on 
the influence of stressful life events on metabolic
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stability. Studies employing a life-events paradigm have 
yet to address the stress-arousal hypothesis. Instead, 
these studies have focused on the indirect effects of 
stress via disruption of compliance behaviors.
Nonetheless, life-events investigations represent an 
improvement over the previously discussed stress-arousal 
studies because of their greater external validity and 
more accurate representation of the effect of naturally- 
occurring events on metabolic stability. A review of 
available literature regarding the stress-corapliance 
hypothesis will now be presented.
Using both adolescent and adult IDDM patients, 
Schafer, McCaul, and Glasgow (1986) had subjects self­
monitor blood glucose testing, diet, and insulin use for 
two 1-wk periods (at initial contact and at 6 month 
follow-up). Compliance was assessed using self-monitoring 
of blood glucose testing, diet, and insulin injections and 
efforts were made to quantify compliance measures.
Research participants also completed the Diabetes Family 
Behavior Checklist (a measure of supportive and 
nonsupportive family behaviors related to diabetes self- 
care) on both occasions. Results for adults indicated 
stressful family interactions were negatively correlated 
with compliance with glucose testing, diet, and insulin 
use. Moreover, compliance with blood glucose testing was 
significantly associated with HbAl (i.e., glycosylated
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hemoglobin, a relatively long-term measure of metabolic 
stability) at 6 month follow-up. No relation between 
stressful family interactions, compliance, and metabolic 
control were found for the adolescents included in the 
sample suggesting possible age effects in the stress- 
compliance relation.
Hanson and Pichert (1986) investigated the effects of 
daily minor stress on compliance in a group of 39 
adolescents at a summer camp for diabetic children. Using 
a stress measure designed specifically for adolescents 
with diabetes, these authors reported stress disrupts 
dietary and exercise compliance. The number and intensity 
of negative stressors were negatively correlated with the 
number of calories consumed, suggesting that as stress 
increased, the amount eaten decreased. Compliance with 
diet was positively related to blood glucose levels while 
compliance with exercise was inversely related to 
metabolic control. Moreover, Hanson and Pichert (1986) 
reported stress had additional effects on blood glucose 
independent of its effects via changes in diet and 
exercise.
In contrast, several researchers have reported the 
effects of stress to be independent of compliance to 
treatment regimens. Using the Hassles Scale, a monthly 
measure of minor stress (Kanner et al., 1981), Cox et al. 
(1984) investigated the stress-compliance hypothesis in 60
adult: research participants with 1DDH. Compliance was 
assessed by having subjects rate degree of compliance in 
each of four areas (i.e., insulin use, diet, blood/urine 
glucose testing, and exercise) on a scale from 0 ("not at 
all") to 100% ("completely). With the exception of 
insulin use, compliance measures were pooled to form a 
global compliance measure. Results of the study revealed 
daily stress was positively associated with blood glucose 
control as measured by HbAl, however, self-reported 
compliance was not related to either blood glucose control 
or stress. In addition, stress and compliance ratings did 
not interact, suggesting the effects of stress on 
metabolic control in this study were not moderated by 
compliance with diabetic regimen.
Several studies with adolescent samples also have 
indicated an independent relation between stress and 
compliance (Hanson, Henggeler, & Burghen, 1987a; 1987b). 
Hanson et al. (1987a; 1987b) found both stress and 
compliance directly influenced metabolic control but were 
unrelated to each other. Although the authors conclude 
the link between the direct effects of stress and 
metabolic stability is "probably physiological" no test of 
the arousal hypothesis was included in this study.
More recently, Halford, Cuddihy, and Mortimer (1990) 
conducted a longitudinal investigation of the relations 
among stress, compliance, and metabolic control in 15
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adults with IDDM. Participants monitored blood glucose, 
exercise, diet, and insulin use daily for eight weeks. 
Using a within-subjects design, stress was found to 
predict blood glucose in seven of the 15 subjects.
Similar to the results of the Cox et al. (1984) 
investigation, the effects of stress on metabolic control 
were independent of compliance.
Investigations of the stress-compliance hypothesis do 
little to resolve the stress-metabolism relation. Four of 
the six studies reviewed noted independence between stress 
and compliance effects on metabolic stability. These 
findings contrast with the stress-compliance hypothesis 
and suggest stress does not negatively influence behaviors 
related to compliance. The results of these studies, 
however, must be tempered by a number of methodological 
shortcomings. Specifically, these shortcomings may be 
grouped into three categories, that is, those related to 
the assessment of stress, the assessment of compliance, 
and the assessment of metabolic control.
First, three studies reviewed did not include an 
adequate assessment of stress. In the Halford et al.
(1990) study, subjects rated stress on a 9 point scale 
from "little or no stress" to "extreme stress." Subjects 
were instructed to use the Hassles Scale (Kanner et al., 
1981) as a guide to "what was meant by psychological 
stress" (Halford et al., 1990; p 519). Use of a global
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unstandardized measure of stress may have obscured any 
potential stress-compliance relations. Moreover, it is 
difficult to know whether subject ratings were based on 
the frequency of minor life events or their subjective 
impact. Regardless, use of this means to assess stress 
introduces a source of error into the investigation. 
Similarly, the Hanson and Pichert (1986) study failed to 
use a standardized stress measure. Finally, while the 
negative family interactions employed in the Schafer et 
al. (1986) investigation are suggestive of a stressful 
environment they almost certainly include other constructs 
as well.
Second, four studies used an inadequate assessment of 
compliance. In the investigation by Cox and his 
colleagues (1984), assessment of compliance was based on 
ratings of subjective degree of compliance. Global 
ratings based on retrospective recall do little to explain 
the relation between stress, compliance, and metabolic 
control. Because stress may disrupt performance of 
behaviors related to compliance, a more direct assessment 
of compliance behaviors would serve a more useful purpose. 
In addition, Hanson et al. (1987a, 1987b) pooled adherence 
measures. Schafer, Glasgow, McCaul, and Dreher (1983) 
suggest compliance to one aspect of treatment may be 
independent of other components. Thus, combining
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compliance measures may not adequately portray stress 
effects.
Although Halford et al. (1990) examined components of 
compliance, this investigation also suffers from problems 
associated with compliance measurement. In the dietary 
compliance measure used in the Halford et al. (1990) 
investigation, subjects rated dietary compliance on a 5- 
point scale from "mostly poor foods with no good foods" to 
"mostly good foods with no poor foods" after being 
provided with a list of poor, moderate, and good foods. 
Failure to obtain a diet diary may obscure fluctuations in 
dietary compliance not apparent with a global daily 
rating.
The stress-compliance studies also have 
methodological problems associated with assessment of the 
dependent measure. In order for the results of these 
studies to be meaningful, accurate reflection of metabolic 
stability for the time period under investigation must be 
obtained. Four of six studies used HbAl as the primary 
indicator of metabolic stability. HbAl, while a reliable 
and valid measure of metabolic control, reflects blood 
glucose control over a 6 to 8 week period. More proximal 
measures of metabolic control would appear to give more 
precise information about the stress-compliance relation.
When more proximal measures of metabolic control are 
obtained these measures should be accurate representations
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of metabolic control. In the Halford et al. (1990) 
investigation, subjects self-monitored blood glucose three 
times daily. In question is the means by which subjects 
obtained these measures. According to the authors, some 
subjects used glucometers while others used visually read 
glucostrips to determine blood glucose levels.
Reflectance glucometers are significantly more accurate 
than reading of glucostrips. Use of two means of 
assessing blood glucose may have contributed to the 
negative findings in the Halford et al. (1990) study. In 
addition, no subjects used glucometers equipped with 
memory capability. Ample evidence exists to suggest 
individuals with IDDM may significantly under-report blood 
glucose levels (e.g., Mazze et al., 1984; Gonder- 
Frederick, Julian, Cox, Clarke, & Carter, 1988). Although 
Halford and colleagues indicate memory equipped 
glucometers were not available at the time of their study, 
failure to further investigate stress-compliance relations 
based on potentially erroneous results may be premature.
Summary and Conclusions. Two principal hypotheses 
have been posited regarding the effects of stress on 
metabolic stability in IDDM. First, stress is believed to 
have direct effects on metabolic control through a 
sympathetically-mediated arousal mechanism. Via action of 
the stress hormones, stress may adversely influence 
carbohydrate metabolism leading to metabolic instability.
Previous investigations of the effects of sympathetic 
nervous system arousal in IDDM have relied exclusively on 
the potential disrupting influence of brief laboratory- 
induced stressors. However, these studies fail to support 
an arousal-mediated effect of stress on metabolic outcome 
variables (e.g., Kemmer et al., 1986). Several 
investigators have extensively criticized use of 
laboratory-induced stressors because they lack relevance 
to naturally-occurring stressful events (e.g., Goetsch,
1989). This methodological concern highlights the 
importance of studying stress and its impact in the 
natural environment.
A second hypothesis regarding the effects of stress 
on metabolic control involves its indirect effects on 
compliance with a prescribed treatment regimen. According 
to this hypothesis, behavioral disruption associated with 
the occurrence of stressful events may influence the 
willingness with which individuals with IDDM adhere to 
their diets, perform insulin injections, exercise, or 
monitor glucose. Because compliance with treatment is an 
important variable in maintaining metabolic control, the 
occurrence of stress may increase risk of developing later 
complications of the disease associated with metabolic 
instability.
Research addressing the stress-compliance hypothesis 
has employed a more ecologically valid means of
determining stress than investigations of the stress- 
arousal hypothesis. Yet, while some investigators report 
an adverse effect of life events stress on compliance with 
treatment (e.g., Schafer, HcCaul, & Glasgow, 1986), others 
found the effects of stress to be independent of 
compliance (e.g., Cox et al., 1984; Hanson et al., 1987a; 
1987b). However, these investigations suffer from 
significant methodological problems that may have made 
stress-compliance relations difficult to find.
In summary, investigations of the stress-arousal 
hypothesis have employed a means of assessing stress with 
limited generalizability to naturally-occurring stressors. 
Few investigations have been conducted in this area, and 
they have failed to support a sympathetically-mediated 
arousal effect on metabolic control. To date, there have 
been no investigations of the direct effects of naturally- 
occurring stressors on metabolic control via arousal 
mechanisms. Similarly, the results of investigations of 
the stress-compliance hypothesis have done little to 
explain stress effects on metabolic stability.
THE CURRENT STUDY
This study was designed to investigate the two 
primary hypotheses regarding the effects of stress on 
metabolic control in adults with IDDM. That is, both the 
direct effects proposed to result from a sympathetically- 
mediated arousal process and indirect effects resulting 
from disruption of compliance to treatment regimen were 
examined. Although both hypotheses are generally accepted 
in the DM literature, both have been indadequately 
explored.
Delineating the relative contributions of an arousal- 
mediated process or a process of disruption of compliance 
behaviors has potential impact for treatment of 
individuals with IDDM. Tailoring treatment to the cause 
of the disorder is an important variable in treatment 
outcome. As such, determining the cause of metabolic 
instability resulting from stress would suggest that those 
who respond to stress with a predominant autonomic 
response may best be helped with a stress management 
approach to treatment while those who respond to stress by 
changes in compliance behavior might be more appropriately 
addressed through behavioral management.
The relation between minor life events, compliance 
behaviors, sympathetic arousal, and blood glucose in adult 
patients with IDDM was examined. Specifically, this study 
explored whether naturally-occurring minor stressful
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events have disruptive effects on metabolic control 
through: a) an arousal mechanism, b) disruption of the 
individual's adherence to a prescribed treatment regimen, 
c) a combination of arousal and disruption of compliance, 
or d) a third unspecified mechanism. The present study 
addressed methodological shortcomings of previous 
investigations by simultaneously: a) employing a 
psychometrically sound and ecologically valid means of 
assessing stress, b) quantifying compliance measures, and 
c) using a valid, accurate, and proximal means of 
assessing metabolic control.
Research Questions Addressed by the Study
1. Do naturally-occurring minor stressors influence 
metabolic control by disrupting compliance with diet, 
exercise and/or insulin use? Although much of the 
previous stress-compliance research has been equivocal, it 
is expected that the quantified compliance measures 
employed in the current study will indicate the stress- 
compliance relation does influence metabolic control. 
However, stress may have a relatively greater effect on 
some aspects of the treatment regimen than others. No 
specific hypotheses are made regarding the effects of 
stress on metabolic control via the separate components of 
compliance (i.e., diet, exercise, and insulin use) 
assessed in this study.
2. Do naturally-occurring minor stressors influence 
metabolic control via a sympathetically-mediated pathway? 
Based on available knowledge about the effects of minor 
stressors on cortisol and the effects of cortisol on 
metabolic control, minor stress is expected to exhibit a 
disruptive influence on metabolic stability via changes 
in urinary free cortisol.
3. Do naturally-occurring minor stressors have 
effects on metabolic stability independent of stress- 
compliance and stress-arousal relations? While the 
stress-compliance and stress-arousal hypotheses are the 
primary means by which stress is proposed to have its 
effects on metabolic control, there is no extant reason to 
believe stress may not have effects on metabolic stability 
independent of these relations. However, the stress- 
compliance and stress-arousal hypotheses are expected to 
account for the majority of the variance in predictions of 
metabolic control based on available research.
METHOD
Subjects
Forty-five adult volunteers with IDDM were studied. 
Subjects were patients at the West Virginia University 
Health Sciences Center or the University of Texas Medical 
Branch at Galveston. Subjects were recruited in one of 
two ways: 1) by referral from their primary care physician 
or 2) via newspaper advertisements. None were pregnant 
during the course of the study and none were taking 
medications known to influence the human stress response 
(e.g., beta blockers, calcium channel blockers, steroids, 
or anxiolytics). All subjects had been diagnosed with 
IDDM for a minimum of one year (mean duration = 15.5 
years, SD = 8.99).
Two subjects failed to exhibit correspondence between 
glucometer memory readings and self-reports of blood 
glucose on their daily diaries. This information brought 
into question the reliability of other self-report data 
for these subjects and consequently these subjects were 
dropped from the subject pool. Three additional subjects 
were eliminated because the age at diagnosis of their 
disease (i.e., 44, 45, and 50 years) suggested Type II 
diabetes according to criteria proposed by Welborn, 
Garcia-Webb, Bonser, McCann, and Constable (1983). The 




Demographic data was collected on all subjects (see 
Appendix A). Mean age for the study participants was 33.5 
years with a standard deviation of 10.35, while mean age 
at diagnosis of XDDM was 17.8 years (SD = 9.17). The 
subjects in this study were primarily white (87.5%) and 
had at least a partial college education (77.5%). Forty- 
seven and one-half per cent were married, while the 
remainder were either separated/divorced (17.5%) or never 
married (35%). The majority were employed (62.5%) and had 
an average income of between $10,001 to $15,000 annually. 
Complete demographic data for the sample are presented in 
Table 1.
Informed consent was obtained from all subjects prior 
to involvement in the study. Copies of informed consent 
from both West Virginia University Health Sciences Center 
and the University of Texas Medical Branch are presented 
in Appendix B. Research subjects were compensated for 
their time at the rate of $5.00 per day for each day of 
monitoring completed ($15.00 total). One subject refused 
monetary incentive.
Measures
Daily Stress Inventory. The DSI (Brantley & Jones, 
1989) is a 58 item self-report inventory of daily 
stressful events or minor stressors. Respondents indicate 
which of 58 stressors occurred during the previous 24 
hours and then rate endorsed items on their perceived




Gender Female 19 47.5
White 35 87.5
Race Black 2 5.0
Other 3 7.5
Married 19 47.5
Marital status Divorced/Separated 7 17.5
Never married 14 35.0
Graduate/Professional 8 20.0
College graduate 7 17.5
Educational Partial college 16 40.0
Level High school graduate 8 20.0
Junior high (7-9 yrs) 1 2.5
Full time 20 50.0
Employment Part-time 5 12.5
Status Student 10 25.0
Unemployed 5 12.5
less than $5000 13 32 .5
$5001 - 7500 0 0.0
$7501 - 10,000 1 2.5
Income $10,001 - 15,000 6 15.0
$15,001 - 25,000 8 20.0
$25,001 - 50,000 9 22.5
$50,001 - 100,000 3 7.5
impact using a Likert scale from 1 ("occurred but was not 
stressful") to 7 ("caused me to panic"). Three primary 
scores can be derived from the DSI: 1) the Event Score
represents the number of stressful events reported as 
occurring during the previous 24 hour period, 2) the 
Impact Score is the sum of the perceived impact ratings, 
and 3) the I/E Ratio is the average impact rating for the 
previous 24 hour period. Only the Event and Impact Scores 
were used in the current study. Validity studies of the 
scale indicate good convergent (Brantley et al., 1987) and 
construct (Brantley, Cocke, Jones, & Goreczny, 1988b; 
Goreczny, Brantley, Buss, & Waters, 1988) validity. 
Moreover, data exist to suggest the scale is sensitive to 
fluctuations in urine measures of norepinephrine 
metabolites and cortisol (Brantley et al., 1988a) 
indicating the scale has good convergent validity with 
biochemical indicators of stress. Normative data for the 
scale exist for both normal and medical populations.
Compliance Measures. Measures of compliance with 
treatment regimen were divided into three components; 
compliance with diet, exercise, and insulin use.
Compliance with prescribed diet was assessed by 
having subjects monitor all food intake daily for three 
days. Subjects were provided with monitoring forms on 
which to record food intake (see Appendix C). Data 
obtained from food intake monitoring was then converted to
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the number of exchanges in each of the six food groups 
(i.e., milk, vegetable, fruit, bread/starch, meat, and 
fat) using the Minipress Dietrak software program (N- 
Squared Computing, 1989) for personal computers. The 
number of exchanges eaten in each food group was then 
subtracted from the number of exchanges prescribed in each
group to obtain the total number of exchange deviations
(both additions and deletions) for that day. Finally, the
total number of exchange deviations was summed and divided
by the total number of exchanges prescribed yielding the 
Diet Deviation Score. Dietary compliance was, therefore, 
expressed as a ratio of exchange deviations to the total 
number of exchanges prescribed.
For example, if the individual added two fat 
exchanges and deleted one bread exchange relative to their 
prescribed diet, a total of three exchange deviations 
would be counted for that day. Moreover, if the 
individual's prescribed diet called for 12 planned 
exchanges per day, the total dietary deviation score for 
that day would be .25 or 3/12. Previous research suggests 
this method of quantifying dietary compliance in 
individuals with IDDM is sensitive to metabolic outcome 
measures (Christensen, Terry, Wyatt, Pichert, & Lorenz, 
1983) .
A test of normality of the distribution of diet 
deviation scores (i.e., a Shapiro-Wilk W statistic)
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indicated these scores were normally distributed (Shapiro- 
Wilk W= .95, fi = .20).
To assess compliance with medication, subjects 
recorded the time, type, and amount of insulin used at 
each injection (see Appendix D). Similar to compliance 
with diet, compliance with insulin use was expressed as 
the proportion of insulin deviations from prescribed 
insulin regimen. Deviations in insulin use are 
defined as: a) changes in timing of insulin of more than
one hour or omission of an injection (one deviation); and 
b) inappropriate changes in amount of insulin (one 
deviation). Appropriate changes in insulin timing or 
amount to accommodate meals, exercise, hypo- or 
hyperglycemia were not counted as insulin deviations. The 
sum of each day's insulin deviations was divided by the 
number of insulin injections per day times two (i.e., the 
number of potential sources of error for that injection: 
timing/omission or amount) to obtain the daily insulin 
deviation score.
A Shapiro-Wilk w statistic (Shapiro & Wilk, 1965) 
indicated the distribution of raw insulin deviation scores 
was not normal (Shapiro-Wilk W = .92, p = .01). Cohen and 
Cohen (1983) suggest proportional data be transformed to 
"linearize" the data under these circumstances. An 
arcsine transformation was, therefore, performed on these
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data. In all data analyses, Insulin deviation scores were 
expressed as arcsine transformed proportions.
Exercise compliance was determined by having subjects 
monitor the frequency, duration, and type of exercise 
performed on Exercise Monitoring Logs (see Appendix E). 
Exercise compliance was quantified by multiplying the 
frequency of actual exercise performed during the three 
day monitoring period by 2.3333 to obtain an actual weekly 
frequency score (i.e., 2.3333 days times 3 days of the 
study equals weekly frequency). Actual exercise frequency 
was converted to a weekly exercise frequency score for 
ease of analysis because most physicians instruct patients 
to exercise a set number of times per week (as opposed to 
a set number of times every three days). Actual exercise 
frequency was operationalized as the number of times an 
individual performed discrete exercises (e.g., workouts, 
aerobics). That is, walking in the mall, housework, or 
activities associated with job responsibilities were not 
counted as exercise. The absolute value of the difference 
between the actual weekly frequency score and the 
prescribed frequency score served as the Exercise 
Compliance Score for this study. Ten subjects reported no 
physician recommendations regarding exercise and two 
subjects had missing data for this measure. Data analyses 
for exercise compliance were, therefore, based on 28 
subjects. Data for Exercise Compliance Scores were found
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to be normally distributed (Shapiro-Wilk W = .93, p =
.08).
To assess compliance with prescribed treatment, each 
participant completed a Prescribed Treatment Log (see 
Appendix F). Values from the Prescribed Treatment Log 
were used to determine the denominators in each equation 
involving compliance with diet and medication and 
prescribed frequency of exercise.
Urinary Free Cortisol. Urinary free cortisol levels 
were determined by Flourescence Polarization Immunoassay 
(FPIA) using the TDX Systems (Abbott Laboratories; North 
Chicago, Illinois). All assays were conducted within four 
weeks of collection and urine samples were kept frozen at 
-20 C until the assays were performed. Urine samples 
were returned to room temperature and thoroughly mixed 
prior to testing. Samples containing large amounts of 
particulate matter were centrifuged before assaying.
To control for differences in volume of urine 
collected, creatinine levels also were assayed for each 
urine sample. Creatinine level was determined by 
Radiative Energy Attenuation (REA) using the TDX Systems 
(Abbott Laboratories; North Chicago, Illinois). Use of 
REA technology for creatinine assay is reported to be 
extremely accurate when compared with reference assays 
(Mean = .99; Abbott Laboratories; North Chicago,
Illinois). All laboratory tests were conducted by trained
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laboratory technicians in the Psychopharmacology 
Laboratory in the Department of Behavioral Medicine and 
Psychiatry at the West Virginia University Health Sciences 
Center. Laboratory technicians were blind to the 
hypotheses of the research.
The distribution of cortisol:creatinine raw data 
indicated a non-normal distribution (Shapiro-Wilk W = .87, 
E < .0001). An arcsine transformation was, therefore, 
performed on these data as suggested by Cohen and Cohen 
(1983). In all data analyses, urinary free cortisol 
levels were expressed as an arcsine transformed ratio of 
cortisol:creatinine.
Blood Glucose. Blood glucose levels were determined 
four times daily through use of the One Touch Blood 
Glucose Monitoring System (Lifescan, Milpitas,
California). The One Touch System, a second-generation 
blood glucose monitoring system, determines blood glucose 
levels when a drop of blood is placed on a glucose oxidase 
regeant strip. Unlike many other blood glucose monitoring 
devices, the One Touch System does not require timing or 
removal of blood from the regeant strip and consequently 
reduces potential sources of user error (Jovanovic- 
Peterson, Peterson, Dudley, Kilo, & Ellis, 1988). In 
addition, research comparing blood glucose levels 
determined by the One Touch System with those of a glucose 
analyzer indicate excellent precision and accuracy
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(Jovanovic-Peterson, Peterson, Dudley, Kilo, & Ellis,
1988).
Use of the One Touch requires individuals to lance 
the side of a finger with a lancet pen to obtain a droplet 
of blood. Blood is then placed on a regeant strip and 
entered in the One Touch System. Blood glucose levels are 
digitally displayed to the user in mg/dL and as many as 
250 previous results can be held in memory. For the 
present study, subjects were informed the One Touch System 
had memory capability and they were asked to record their 
daily blood glucose levels on a monitoring sheet (see 
Appendix D). Blood glucose levels for data analysis were 
expressed as daily means.
Procedure
After an initial screening interview, the purpose of 
the study and potential risks were explained to all 
subjects. The primary investigator was available to 
answer questions from subjects when obtaining informed 
consent.
Eligible participants were first trained to self­
monitor blood glucose. All subjects were trained to use 
the One Touch System according to Lifescan protocol. In 
addition, each subject was provided written instructions 
on use of the One Touch. Research participants were 
considered adequately trained when two consecutive trials 
were achieved with blood glucose values within five
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percent of each other (mean across subjects = 3.8%). Each 
participant was provided with a One Touch System including 
sufficient lancets, alcohol prep pads, and regeant strips 
to complete four blood glucose readings daily for three 
days. Subjects were instructed to record blood glucose 
before breakfast, lunch, dinner, and retiring each day and 
enter the obtained values in their monitoring logs.
Each subject completed the DSI daily for four days at 
approximately the same time before retiring for the 
evening. Data from DSI recording on the first day was 
discarded because research has indicated the DSI is 
reactive on the first day of monitoring (Brantley et al., 
1988b). In addition, Brantley et al. (1988b) found 
differences between DSI scores on weekdays and weekends, 
therefore, all self-monitoring was conducted on weekdays 
to control for this potential source of variance.
Beginning on Day Two of DSI recording, subjects also 
completed monitoring forms for compliance assessment daily 
for three days. Participants were instructed to record 
foods consumed, insulin injections, and exercise on their 
self-monitoring forms. Subjects were instructed to 
continue to eat, exercise, and use their insulin just as 
they did before involvement in the study in an effort to 
decrease reactivity.
Finally, participants were asked to collect all urine 
voided between the hours of 2 p.m. and 4 p.m. (to control
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for diurnal variations in cortisol output) in labeled 
urine collection containers provided to each subject. 
Collection of urine for cortisol assay began on Day Two of 
DSI recording concurrent with self-monitoring of 
compliance and continued for three consecutive days.
Urine samples were then frozen by the subjects at the end 
of the each day and returned to the principal investigator 
at the end of the three day monitoring period.
Following the three days of urine collection, DSI 
recording, and compliance self-monitoring, subjects 




Preliminary descriptive statistics of the measures 
employed in the study (i.e., DSI Event and Impact scores, 
insulin deviation scores, diet deviation scores, exercise 
compliance scores, cortisol, and blood glucose) were 
conducted. The mean DSI Event Score was 15.74, placing 
the research participants of this study at the 83rd 
percentile (T=60) in terms of frequency of minor stressful 
events compared to other medical patients. Similar 
results were obtained with the DSI Impact Score (mean = 
39.47, 83rd percentile, T=60). The mean blood glucose 
reading was 181.51 mg/dL for this sample. Table 2 
contains means and standard deviations for other measures 
used in the study.
To determine if research participants from Texas and 
West Virginia differed substantially on any of the 
demographic, independent, or dependent variables, a series 
of T-tests was conducted. Results of these analyses 
indicated no difference between subjects from Texas and 
West Virginia on any study variable. These data are 
presented in Table 3.
Correlations
Correlations were used to examine the interrelations 
between variables. An 8 X 7 correlation matrix of 
demographic measures with the primary predictor and
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Table 2. Descriptive Statistics for Primary Study 
Variables.
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Variable Mean Standard Deviation
DSI Impact Score 39.47 24.88
DSI Event Score 15.74 11.46
Blood Glucose (mg/dL) 181.51 54.99
Diet Deviation Score 1.05 .35
Insulin Deviation Score3 0.34 0.32
Exercise Compliance Score 2.60 1.48
Cortisol:Creatinine 
ratio3 0.12 .06
Note. a Arcsine transformed variable.
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Table 3. T-tests for Differences Between States on 
Demographic and Primary Measures of Study.
Variable t E
Age .76 ns
Age at diagnosis -1.49 ns
Education .22 ns
Employment status 1 H • to to ns
Marital status -0.55 ns
Income 1.64 ns
Blood glucose -0.76 ns
DSI Impact Score -0.44 ns
DSI Event Score -1.72 ns
Cortisol:creatinine 
ratio3 1.18 ns
Diet deviation score -0.03 ns
Insulin deviation score3 -0.31 ns
Exercise compliance score H•01 ns
Note. a Arcsine transformed variables.
outcome measures was generated to examine possible 
intercorrelations between demographic and 
predictor/outcome variables. The eight demographic 
variables included in this correlation matrix were: age, 
ethnic group, gender, marital status, education, 
employment status, income level, and age at diagnosis.
The seven predictor/outcome variables were mean DSI Impact 
and Event scores, mean diet deviation score, mean insulin 
deviation score, mean exercise compliance score, mean 
cortisol:creatinine ratio, and blood glucose. An alpha 
level of .01 was used to indicate statistical significance 
to control for experimenter-wise error. The results are 
presented in Table 4. Race demonstrated a significant 
negative correlation with blood glucose (r = -.45, p <
.01). This suggests that the nonwhite research 
participants in this study had lower blood glucose levels 
than the white participants had. No other correlations 
between demographic and predictor or outcome variables 
were significant.
A 7 (predictor/outcome variables) X 7 
(predictor/outcome variables) correlation matrix also was 
generated, with statistical significance again set at p = 
.01. These results are presented in Table 5. The 
correlation between DSI Impact and DSI Event Scores was 
significant (r = .74, p < .01). The significant 
correlation between DSI Impact and Event Scores suggests
Table 4. Correlation Matrix of Demographic and Predictor/Predicted Variables.
VARIABLE Age Race Gender MaritalStatus Education Employment Income
Age at Diagnosis
DSI Impact Score -0.37 -0.11 0.16 0.30 0.18 0.15 -0.36 -0.27
DSI Event score -0.25 0.05 0.12 0.25 0.08 0.06 -0.25 -0.13
Diet Deviation score -0.05 -0.11 -0.16 -0.02 0.04 -0.20 0.22 0.16
Insulin Deviation Score 0.15 -0.27 -0.17 -0.08 -0.02 -0.15 0.11 0.07
Exercise Compliance Score -0.07 0.08 -0.15 0.19 -0.14 0.13 -0.26 0.06
Cortisol:Creatinine 
Ratio -0.05 -0.02 -0.02 -0.17 0.17 0.05 -0.11 -0.03
































































that either variable may be used to accurately represent 
an individual's experience of daily minor stress.
However, Brantley and Jones (1989) suggest DSI Impact 
Scores may be the best indicator of an individual's 
experience of stress because the score takes into account 
personal appraisal of events. Therefore, only the DSI 
Impact Scores were used to quantify minor stress in the 
subsequent analyses (i.e., simple and multiple 
regressions).
A significant positive relation between DSI Impact 
Score and cortisol also was demonstrated (r = .39, p < 
.01). However, neither DSI Impact nor DSI Event Scores 
were significantly correlated with any other 
predictor/outcome variables. Finally, intercorrelation 
was noted between blood glucose and the insulin deviation 
score (r = .43, p < .01).
No relation between compliance measures was found. 
Lack of significant correlations between the three 
compliance measures (i.e., diet, exercise, and insulin 
use) indicated the need for separate regression analyses 
for each of these predictor variables in subsequent 
analyses. All other correlations were nonsignificant. 
Simple Regressions
Whereas zero-order correlations indicate strength of 
association between two variables, simple regression 
allows determination of the amount of variance in a given
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variable that can be predicted when the value of a second 
variable is known. Four separate regressions were, 
therefore, performed using DSI Impact Score as the 
regressor to investigate the degree to which diet 
compliance, insulin compliance, exercise compliance, or 
cortisol levels can be predicted when daily minor stress 
is known. The results of these analyses are shown in 
Table 6. The regression of DSI Impact Score on diet 
deviation score was nonsignificant, r2 (l,24) = .000, as 
was the regression of DSI Impact on insulin deviation, 
r2 (l,38) = .010, and exercise compliance, r2 (l,26) = .035. 
However, a significant relation between DSI Impact and 
cortisol, r2(l,38) = .151, p < .01, was found.
A second series of simple regressions were conducted 
to determine if blood glucose (i.e., metabolic control) 
can be predicted when compliance and cortisol levels are 
known. In the first of these analyses, the insulin 
deviation score was the regressor. The results of this 
analysis were significant, r2(l,38) = .184, p < .01.
Simple regressions employing cortisol, r2(l,38) = .013, 
diet deviation score, r2 (l,24) = .046, and exercise 
compliance, r2 (l,26) = .000, as regressor variables were 
nonsignificant. The results of these analyses are 
presented in Table 7.
A score for exercise duration also was derived (i.e., 
the absolute value of the difference between actual
Table 6. Results of Simple Regressions with DSI Impact: 
Score as Regressor Variable.
Predicted variable df x2 p
Diet deviation (1,24) .000 ns
Insulin deviation (1,38) .010 ns
Exercise compliance (1,26) .035 ns
Cortisol (1,38) .151 .01**
Note. ** £ < .01
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Table 7. Results of Simple Regressions vith Blood 
Glucose as Predicted Variable.
Predictor variable df r2 E
Diet deviation score (1,24) .046 ns
Insulin deviation score (1,38) .184 **
Exercise compliance (1,26) .000 ns
Cortisol:creatinine
ratio (1,38) .013 ns
Note. ** e  < *01
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exercise duration and prescribed exercise duration) to 
determine if exercise duration successfully predicted 
blood glucose. However, exercise duration also failed to 
exhibit a significant relation with blood glucose, 
r2 (1,26) = .002.
Finally, the direct (i.e., unmediated) relation 
between daily minor stress and metabolic control was 
investigated via a simple regression with DSI Impact Score 
as the regressor variable and blood glucose as the 
predicted variable. The results of this analysis were 
nonsignificant, r2(l,38) = .040.
Multiple Regressions
Multiple regression analyses permit determination of 
the amount of variance accounted for in a predicted 
variable while controlling for the effects of the 
regressor variables. Specifically, hierarchical multiple 
regression was selected because these procedures permit 
entry of the regressor variables in a pre-specified order 
based on theory or the purpose of the research (Cohen & 
Cohen, 1984). Specifying order of entry permits removal 
of variance associated with spurious or confounding 
variables. By entering variables early, and thereby 
removing the variance associated with them, a relatively 
pure test of a given variable's predictive ability can be 
conducted.
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To directly test the effects of an interaction 
between minor stress score and insulin compliance on blood 
gluose (while controlling for the main effects of minor 
stress and insulin compliance), variables were entered 
into a hierarchical regression in the following order:
DSI Impact Score, Insulin Deviation Score, with the DSI 
Impact by Insulin deviation interaction entered last. The 
full model was significant, F(3,36) = 4.09, p - .01, and 
accounted for 25% of the variance. However, the 
interaction of stress and insulin compliance was 
nonsignificant. Only the insulin deviation score was 
significant, nr2 = .215, p < .05. These results are 
presented in Table 8.
Similarly, a second multiple regression was performed 
using minor stress, urinary free cortisol and the DSI 
Impact Score by cortisol interaction to explore the 
relation between stress, cortisol and metabolic control. 
Variables were entered into the equation in the following 
order: DSI Impact Score, cortisol, and DSI Impact X
cortisol interaction. Blood glucose served as the 
predicted variable. This order of entry allows for a 
direct test of the effects of a minor stress by cortisol 
interaction in the prediction of blood glucose. As 
expected based on the results of the simple regressions 
(i.e., no significant relation between cortisol and blood 
glucose), the full model for this regression was
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Table 8. Regression of Daily Minor Stressors. Insulin
Compliance, and Their Interaction on Blood
Glucose.





Variable Partial r2 £
DSI Impact Score .051 ns
Insulin Deviation Score .215 .04
Interaction .013 ns
66
nonsignificant, F(3,36) = .52, and none of the regressor 
variables successfully predicted blood glucose. The 
results of this regression are presented in Table 9.
A multiple regression to explore the interaction of 
stress and diet compliance also was conducted. Variable 
entry in the regression equation was as follows: DSI
Impact Score, Diet deviation score and the DSI Impact by 
diet interaction, with blood glucose as the predicted 
variable. As presented in Table 10, the full model was 
nonsignificant, F(3,22) = .46, and no regressor variable 
predicted blood gluocse.
An identical analysis using exercise compliance and 
the DSI Impact X exercise compliance interaction also 
yielded nonsignificant results (see Table 11). To 
determine if the influence of daily stress on blood 
glucose was mediated by exercise duration, a hierarchical 
multiple regression was performed using (in order of 
entry) the exercise duration score and the DSI Impact X 
exercise duration interaction as regressor variables. 
However, neither exercise duration or a DSI Impact X 
exercise duration interaction successfully predicted blood 
glucose, F(3,24) = .69.
Hierarchical multiple regression also was performed 
to examine the direct effects of insulin compliance on 
metabolic control controlling for the effects of stress. 
Order of entry for the predictor variables for this
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Table 9. Regression of Daily Minor Stressors. Cortisol,
and Their Interaction on Blood Glucose.
Source df F B2 E
Model 3 .520 .04 ns
Error 36
Total 39
Variable Partial r2 e
DSI Impact Score .040






Table 10. Regression of Daily Minor Stressors. Diet
Compliance, and Their Interaction on Blood
Glucose.





Variable Partial r2 £
DSI Impact Score .000 ns
Diet deviation score .046 ns
Interaction .013 ns
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Table 11. Regression of Daily Minor Stressors. Exercise
Compliance, and Their Interaction on Blood
Glucose.





Variable Partial r2 £
DSI Impact Score .000 ns
Exercise compliance score .0006 ns
Interaction .092 ns
analysis were DSI Impact Score and insulin deviation 
score. Blood glucose served as the predicted variable. 
The DSI Impact Score was entered first followed by the 
insulin deviation score. Because the goal of this 
analysis was to examine the unique variance associated 
with insulin compliance on metabolic control, the results 
are presented in terms of semipartial correlation 
coefficients as suggested by Cohen and Cohen (1983). 
Semipartial correlation coefficients represent the 
correlation between the predicted variable and the
independent variable in question after the effects of the
shared variance of the two (or more) independent variables 
have been removed (Edwards, 1984). The full model was 
significant, F(2, 37) = 5.98, p < .01, and accounted for 
24% of the variance. Insulin compliance was found to 
successfully predict blood glucose independent of stress 
and account for 20% of the variance in metabolic control,
sr2 = .204, p < .01 (see Table 12).
Similarly, to determine if diet compliance influenced 
blood glucose independently of stress, a hierarchical 
multiple regression with DSI Impact score entered first 
followed by the Diet Deviation Score was performed. Blood 
glucose was the predicted variable. The full model was 
nonsignificant, F(2,23) = .56. Diet compliance was not 
found to influence blood glucose independently of stress 
(sr2 = .045). Cortisol (F(2,37) = .80, sr2 = .001) and
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Table 12. Direct Effects of Insulin Compliance on Blood
Glucose Controlling for the Effects of Daily 
Minor Stressors.













exercise compliance (F(2,25) = .18, sr2 = .0005) also had 
no direct effects on blood glucose when the variance 
associated with stress was statistically removed.
A final hierarchical regression employed blood 
glucose as the predicted variable and insulin compliance, 
cortisol, and DSI Impact Score as predictor variables.
The DSI Impact Score was the final variable entered into 
the equation to determine if minor stress had direct 
effects on metabolic control not accounted for by a 
stress-arousal or stress-compliance relation. Diet and 
exercise compliance were not included in this analysis 
because neither of these components of compliance had been 
shown in previous analyses to influence blood glucose.
The cost to statistical power of including these 
variables, did not, therefore, appear justified. The full 
model was significant (F(3,36) = 4.04) and accounted for 
25% of the variance in blood glucose. However, as shown 
in Table 13, the only significant predictor of blood 
glucose was the Insulin deviation score (sr2 = .201, p < 
.01) .
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Table 13. Regression of Insulin Compliance. Cortisol, and
Daily Minor Stressors on Blood Glucose.
Source df F R2 p
Model 3 4.04 .25 .01
Error 36
Total 39
Variable sr2 Model p
R2
Cortisol:creatinine .013 .01 ns
Insulin deviation score .201 .21 .003
DSI Impact score .038 .25 ns
DISCUSSION
Minor stress did not influence short-term metabolic 
control either independently or via a stress-compliance 
or stress-arousal mechanism in this sample of individuals 
with IDDM. Consistent with previous research (i.e., 
Brantley et al., 1988a), stress was related to cortisol 
activity, but neither the direct effects of cortisol nor a 
cortisol by stress interaction successfully predicted 
metabolic control. Moreover, stress was unrelated to diet 
or exercise compliance and no relation between diet or 
exercise compliance and metabolic control was found. Only 
insulin compliance was found to influence metabolic 
control, although the effects of insulin compliance were 
independent of a stress-compliance relation.
Stress has been repeatedly portrayed in the 
literature as influencing metabolic control in Type I 
diabetes, yet the results of the current study suggest no 
relation between stress and metabolic control for this 
sample. The inability to find a stress-blood glucose 
relation is consistent with some previous research (e.g., 
Edwards & Yates, 1985; Kemmer et al., 1986). However, 
other groups have reported significant relations between 
metabolic disruption and stress (e.g., Cox et al.,




Several potential reasons for the negative findings 
of the current study exist. First, several of the studies 
reporting a stress-blood glucose relation used adolescent 
samples (i.e., Hanson et al., 1987a, 1987b; Hanson & 
Pichert, 1986). Although poorly understood, adolescents' 
metabolic response to stress may be different from that of 
adults (Brand et al., 1986; Chase & Jackson, 1981).
Schafer et al. (1986) found a differential effect of age 
regarding the stress-glucose relation in a mixed sample of 
adults and adolescents. The lack of comparability between 
stress' influence on blood glucose in adults and 
adolescents suggests it may be inappropriate to compare 
the results of the current study to investigations 
employing adolescent or mixed samples.
Second, the current study improved over past 
investigations by improving assessment of both the 
independent and dependent measures (i.e., stress and blood 
glucose). Use of the DSI to assess daily minor stress 
provided a reliable, valid, and standardized means of 
assessing naturally-occurring stress. Many previous 
investigations relied on unstandardized stress measures 
(e.g., Halford et al., 1990; Hanson & Pichert, 1986) 
making comparisons with the current study problematic.
It should be noted, however, that the results of the 
current study are consistent with the results of the 
carefully controlled laboratory stress study by Kemmer et
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al. (1986). Perhaps, when stress is validly assessed (as 
in the current investigation and the Kemmer et al. study) 
no reliable relation between stress and blood glucose 
exists.
Moreover, the present study used an extremely 
accurate and proximal measure of metabolic control, that 
is, multiple daily reflectance glucometer readings as 
opposed to the more distal HbAl. Much of previous 
research relied exclusively on HbAl to assess metabolic 
control (e.g., Cox et al., 1984). Improved accuracy in 
the assessment of the variables under investigation 
increases the probability that any existing stress-blood 
glucose relation would be found. Methodological 
shortcomings of the past research may have indicated the 
presence of stress-metabolic relations where none actually 
existed. Conversely, daily minor stress may have a 
cumulative long-term effect on blood glucose (i.e., as 
measured by HbAl), but not influence short-term glycemic 
control as assessed by reflectance glucometers.
A third possible explanation for the negative 
findings of the current study involves the experimental 
design. The study employed a cross-sectional approach 
that may have obscured any significant relations between 
stress and metabolic control by collapsing data across 
subjects. That is, some individuals in the study may have 
experienced metabolic disruption in response to stress,
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but there may have an insufficient number of these 
individuals to override the effects of those who 
experienced no metabolic effects. Carter, Gonder- 
Frederick, Cox, Clarke, and Scott (1985) found 
idiosyncratic metabolic responses to stress within- 
subjects that were stable across time suggesting 
individual differences in stress-responsivity. Similarly, 
Halford et al. (1990) used a within-subjects design and 
found stress influenced blood glucose in only seven of 15 
subjects.
These data suggest only certain individuals with IDDM 
may respond to stress via metabolic disruption while 
others may be relatively metabolically insensitive to the 
influence of stress. Within-subjects designs require 
observation of the study variables over a sufficiently 
long period of time to provide ample variance in the 
variables of interest. The three days of self-monitoring 
used in the current study, however, did not allow for 
examination of within-subject differences. It may be that 
with longer periods of investigation using within-subjects 
designs stress-glucose relations could be found.
Finally, much of the previous literature on the 
direct unmediated effects of stress on blood glucose has 
included both Type I and Type II (noninsulin-dependent; 
NIDDM) patients (see Goetsch, 1989 for a review). Stress 
may disrupt metabolic control in Type II patients while
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having little or no impact on IDDM. In support of this 
notion, Goetsch et al. (1990) found a significant relation 
between daily minor stress and metabolic control in Type 
II patients while controlling for the influence of diet 
and exercise.
Moreover, research investigating the effects of 
relaxation training (which would presumably attenuate the 
influence of stress) on metabolic control suggests that 
IDDM and NIDDM patients may be differentially affected. 
Several studies have reported a positive influence of 
relaxation training in Type II patients (Surwit &
Feinglos, 1988; Lammers, Naliboff, & Straatmeyer, 1984) 
but not Type I (Bradley, Moses, Gamsu, Knight, & Ward, 
1985; Landis et al., 1985; Feinglos, Hastedt, & Surwit, 
1987). Surwit and Feinglos (1988) conclude that stress- 
related arousal of the sympathetic nervous system may be 
more important in the pathophysiology and metabolic 
disruption of Type II than Type I patients. While 
individuals with IDDM may perceive stress to be an 
important factor in metabolic control (Cox et al., 1984), 
this may not actually be the case.
The present study was designed to investigate how 
stress influenced short-term metabolic control, that is, 
by disrupting compliance with treatment or through an 
autonomically-mediated mechanism via cortisol activity. 
While the negative results of an unmediated stress-glucose
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relation make the stress-arousal and stress-compliance 
issues something of a moot point, several additional 
findings of the study warrant comment.
Stress and Arousal
The study represents the first investigation of the 
arousal hypothesis using naturally-occurring daily minor 
stress. Previous research (i.e., Delameter et al., 1988; 
Kemmer et al., 1986) examining the influence of laboratory 
stress has been unable to support an arousal-mediated 
relation between stress and metabolic control. The 
results of the current study are consistent with the 
findings of this literature. The methodological 
improvements of the current research (i.e., use of a more 
externally valid means of assessing stress and controlling 
for diurnal variations in cortisol secretion) lend 
additional creedence to this body of literature. At least 
in terms of relatively brief stress, influences on 
metabolic control may not be secondary to an arousal- 
mediated mechanism. This finding, however, does not rule 
out the possibility of potential long-term stress 
influences on glycemic control.
In addition, the negative results of the current 
study are supported by replication of the findings of 
Brantley et al. (1988a) involving the influence of daily 
minor stress on cortisol. Had the present study failed to 
find the expected positive relation between stress and
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cortisol, the negative findings of the stress-arousal 
hypothesis on metabolic control may have been more easily 
challenged. Failure to find a stress-arousal influence on 
metabolic control supports previous research and suggests 
an arousal-mediated influence of minor stress on metabolic 
control may not be tenable.
While the results of this study are consistent with 
the previous literature on the stress-arousal relation, 
several possible explanations for the negative findings 
remain. Like the Kemmer et al. (1986) study, increases in 
cortisol activity may have been "biologically 
insufficient" to disrupt metabolic control. Although 
stress was predictive of cortisol in this study, the 
increases in cortisol may have been inadequate to reach 
the biological thresholds required to result in metabolic 
instability. It is possible that daily minor stressors, 
like laboratory stressors, do not have sufficient 
biological impact to cause autonomic activity adequate for 
metabolic disruption.
Second, cortisol alone may not accurately represent 
the activity of the autonomic nervous system. Assessment 
of a more global autonomic response including 
catecholamines and GH may more accurately reflect 
autonomic arousal. While Kemmer et al. (1986) did assess 
a number of other indicators of autonomic arousal in 
addition to cortisol, they failed to demonstrate a
relation between these biological indicators of stress and 
blood glucose control. However, Kemmer et al.'s results 
with other autonomic indicators have not been replicated 
with naturally-occurring stressors and were not assessed 
in the current study. Further research using an 
externally valid means of assessing stress and a broader 
spectrum assessment of autonomic activity will be required 
to address this question.
Finally, it may be that the sample of individuals 
with IDDM in the study are not representative of the 
general population with IDDM. Participants in the study 
were in relatively good control of their blood glucose and 
free from any long-term complications of the disease. 
Perhaps the effects of an arousal-mediated mechanism of 
stress becomes more apparent with increasing severity of 
disease and the presence of complications. In support of 
this possibility is Kemmer et al.'s (1986) finding that 
cortisol levels were higher in hyperglycemic IDDM patients 
compared to normoglycemic patients. Individuals with 
poorer metabolic control (i.e., more severe disease) may, 
therefore, be more susceptible to the effects of stress.
It should be noted, however, that length of illness was 
not found to be related to either cortisol or stress in 




The preliminary correlations conducted indicated no 
relation between diet, exercise, and insulin compliance. 
This finding is consistent with previous research 
suggesting independence of the separate components of 
compliance (Schafer et al., 1983). Nonetheless, many 
investigations of the influence of compliance on metabolic 
control have used a composite or pooled compliance measure 
(e.g., Hanson et al., 1987a, 1987b) combining several 
aspects of compliance with treatment. The preliminary 
correlations of the present study suggest combining 
separate aspects of compliance may be inappropriate.
While the independence of the separate components of 
compliance found in this study must be interpreted 
cautiously because of the relatively small sample size, 
the finding may have important implications for future 
research. To more accurately portray the relation between 
compliance and metabolic control, future research would 
benefit from examination of independent compliance 
behaviors rather than an overall compliance construct.
This would allow determination of the specific areas in 
which an individual may be experiencing difficulties and 




Daily minor stress was unrelated to diet, exercise, 
or insulin compliance in this study. In addition, no 
effect of the interaction between the separate components 
of compliance and stress was found suggesting independence 
of stress and compliance effects. These findings are 
consistent with the majority of past research (e.g., Cox 
et al., 1984; Halford et al., 1990) indicating 
independence of stress and compliance influences on 
metabolic control. However, the methodological 
improvements of the current study (i.e., quantified 
compliance assessment and use of a standardized means of 
assessing naturally-occurring stress) supports this body 
of literature and suggests stress-compliance relations may 
not influence short-term metabolic control in IDDM.
Insulin compliance was related to metabolic control 
in this sample. The relation between insulin compliance 
and blood glucose was in the expected direction; that is, 
the less compliant individuals were with taking their 
insulin (i.e., the higher the insulin deviation score), 
the poorer their metabolic control. Insulin compliance 
was found to predict 20% of the variance in metabolic 
control independent of the perceived impact of daily minor 
stress. These findings are consistent with required 
treatment for IDDM and make intuitive sense. If insulin 
is not taken, blood glucose levels rise.
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Perhaps more surprising are the negative findings 
regarding the influence of diet compliance on metabolic 
control. Diet compliance accounted for only 5% of the 
variance in metabolic control in this study, but 
interpretation of these results must be made cautiously. 
The data analyses regarding diet compliance are not based 
on the total sample. As was discussed in the Methods 
section, the number of dietary exchanges prescribed was 
used as the denominator in the diet deviation ratio. 
Derivation of the number of exchanges prescribed was based 
on the total number of calories in a given individual's 
American Diabetes Association (ADA) prescribed diet 
(Powers, 1987). However, only 26 of the subjects in the 
study were able to indicate the number of calories 
prescribed in their ADA diets. The fourteen remaining 
subjects reported no knowledge of the number or type of 
calories they were meant to eat and therefore could not be 
included in the data analysis.
This finding suggests significant lack of knowledge 
regarding dietary recommendations for treatment of IDDM in 
at least a portion of the subjects in this study. In 
addition, it brings into guestion how one can reasonably 
expect individuals with IDDM to comply with dietary 
treatment recommendations if they do not have knowledge or 
understanding of these recommendations. That is, how can 
compliance with diet be accurately assessed if the people
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with the disorder do not know what is expected of them?
While this finding is epiphenomenon to the specific 
objectives of the current study, it represents an 
important result. Do the negative results of the diet 
compliance data reflect an actual lack of relation between 
dietary adherence and metabolic control or are the results 
confounded by those subjects who indicated limited 
knowledge of their dietary treatment recommendations? 
Similarly, does the lack of reported knowledge about the 
number of calories prescribed in an ADA diet indicate a 
special case of noncompliance?
The means by which the data were analyzed in the 
current study does not allow for resolution of these 
questions. However, these results do suggest directions 
for both future research and clinical endeavors. Future 
research appears needed to determine if those individuals 
who report a lack of knowledge about their dietary 
treatment recommendations differ in other aspects of 
compliance behaviors (or more generally) from those 
individuals with IDDM who do report knowledge of this area 
of their treatment. Research to this end may help resolve 
some of the questions surrounding the compliance-blood 
glucose issues and would improve the accuracy with which 
the stress-compliance hypothesis can be investigated.
A second point to be gained from this finding 
suggests future research involving quantification of diet
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compliance should seek to determine those individuals who 
are knowledgeable about their diet versus those who are 
not a priori. These results also have clinical 
implications and suggest that more frequent sessions with 
a nutritionist to review and revise dietary needs may be 
useful to improve both general IDDM care and dietary 
compliance.
Summary and Implications for Future Research
This study was conducted to examine the relation 
between daily minor stress, compliance behaviors, cortisol 
activity and short-term blood glucose control in IDDM. 
Improvements in methodology over previous research were 
made by simultaneously: a) employing a psychometrically 
sound and ecologically valid means of assessing stress; b) 
quantifying compliance measures; and c) using a valid, 
accurate, and proximal means of assessing metabolic 
control.
The results of the study indicated daily minor stress 
did not influence short-term metabolic control, either 
through a direct unmediated influence, via disruption of 
compliance with treatment, or an autonomically-mediated 
mechanism. Insulin compliance was found to negatively 
influence blood glucose control, however, diet and 
exercise compliance and cortisol activity had no impact on 
the dependent measure. Daily minor stress was found to 
predict cortisol activity.
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The results of the current study suggest several 
lines for further research. First, within-subjects 
studies examining the role of naturally-occurring stress 
on metabolic control appear needed. These studies should 
be done in conjunction with efforts to more accurately 
quantify compliance measures as was done in the current 
study. Within-subjects designs would allow for 
determination of those individuals who may be most 
susceptible to the influence of stress on metabolic 
control. The ability to identify stress-reactive prone 
individuals may allow for improved treatment tailored to 
the specific needs of the patient.
Second, studies comparing samples of Type I and Type 
II diabetes appear to be needed to address potential 
differences in stress-responsivity in these two groups of 
patients. Available research suggests these studies may 
be best conducted using a longitudinal design allowing for 
examination of individual difference influences on 
outcome. In addition, future research should employ 
assessment of a wider range of indicators of autonomic 
activity including catecholamines and GH.
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I have been asked to participate as a subject in the 
research project titled The relation between stress and 
insulin-dependent diabetes mellitus under the direction of 
Diane Garrett, M.S. The purpose of the study is to 
examine the effects of daily stress on blood glucose in 
persons with Type I diabetes. It is the goal of this 
study to further knowledge about the effects of stress on 
individuals with diabetes.
I understand the experimenter will show me how to use a 
digital glucometer, how to lance my finger for a drop of 
blood, and how to record the reading on a monitoring form. 
I will be given forms to record my blood glucose, diet, 
exercise, insulin use, and daily stress. I will be asked 
to record these readings for three (3) consecutive days.
I also understand I will be asked to collect a urine 
sample in the containers provided to me for the same three 
(3) day period. I understand I will be asked to freeze 
each urine sample at the end of the day and return the 
samples to the experimenter at the end of the study. The 
experimenter may phone me periodically to insure I am not 
having difficulty with any of the recording procedures.
Following the three (3) day monitoring period, I 
understand I will then be asked to return my forms, 
glucometer, and urine samples to the experimenter. I also 
will be asked to complete a questionnaire at that time. 
Before I leave I will be paid and the results of the study 
explained to me.
I understand there are no alternate procedures to this 
project other than to decline participation. I also 
understand there are no costs or special fees for 
participating.
I understand that I will not directly benefit from my 
participation in the research project. However, my 
involvement in this project will serve to further 
knowledge about the effects of stress on individuals with 
diabetes.
The potential risks associated with the study are minimal.
When I return to the laboratory for the completion of the 
study, I understand I will receive monetary compensation 
of $5.00 for each day of home monitoring I completed if I 
complete all three days of monitoring.
I also understand that any information collected in this 
study will not identify me personally. I understand that
102
I will be assigned a number at the onset of my involvement 
in the study and that this number will be used for 
identification purposes. It has been explained to me that 
every effort will be made to insure my confidentiality by 
using an assigned number on all questionnaires and 
monitoring forms.
In signing this consent form, I state that I have read and 
understand the description of the monitoring forms and 
questionnaire as well as the following statements. I 
understand I will be given a copy of the consent form.
1. I understand that informed consent is required of all 
persons in this project.
2. The principal and alternate procedures, including the 
experimental procedures in this project have been 
identified and explained to me in a language that I 
can understand.
3. The risks and discomforts from the procedures have 
been explained to me.
4. The expected benefits from the procedures have been 
explained to me.
5. An offer has been made to answer any questions I may 
have about these procedures. If I have any questions, 
before, during, or after the study, I may contact Ms. 
Diane Garrett at (409) 772-6730.
6. I have been told that I may refuse to participate or
stop my participation in this project without
prejudice and without jeopardizing my medical care at
UTMB. All new findings during the course of the 
research which may influence my desire to continue or 
not to continue to participate in this study will be 
provided to me as such information becomes available.
7. I have been told that the University of Texas Medical
Branch like virtually all other universities in the
United States, does not have a mechanism for 
compensation of the injured research subject. 
Therefore, I understand I cannot look to any such 
mechanism to receive financial remuneration for any 
such injuries resulting in my participation in this 
project. If physical injury occurs as a direct result 
of this research, emergency treatment which is 
available to the general public will be available to 
me. Neither UTMB or Diane Garrett, M.S. can assume 
financial responsibilities or liability for the 
expense of such treatment.
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8. I understand that if I have any questions about my 
rights as a patient participating in this study or a 
research-related injury, I may contact Dr. E. Ray 
Stinson, Director of the Office of Sponsored Programs- 
Academic at (409) 772-2482.
9. I understand that I have a right to privacy and all 
information that is obtained in connection with this 
study and that can be identified with me will remain 
confidential as far as possible within state and 
federal law. However, information gained from this 
study and that can be identified with me may be 
released to no one other than the investigator and my 
physician. The results of this study may be published 
in scientific journals without identifying me by name.
I voluntarily agree to participate as a subject in the 
above named project.
Date Signature of Subject
Signature of Witness
Using language that is understandable and appropriate, I 
have discussed this project and the items listed above 
with the subject and/or his/her authorized representative.
Date Signature of Project Director
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West Virginia
The purpose of this research is to examine the 
effects of daily stress on blood glucose in persons with 
Type I diabetes. It is the goal of this study to further 
knowledge about the effects of stress on individuals with 
diabetes.
I understand the experimenter will show me how to use 
a digital glucometer, how to lance my finger for a drop of 
blood, and how to record the reading on a monitoring form. 
I will be given forms to record my blood glucose, diet, 
exercise, insulin use, and daily stress. I will be asked 
to record these readings for three (3) consecutive days.
I also understand I will be asked to collect a urine 
sample in the containers provided to me for the same three 
(3) day period. I understand I will be asked to freeze 
each urine sample at the end of the day and return the 
samples to the experimenter at the end of the study. The 
experimenter will phone me periodically to insure I am not 
having difficulty with any of the recording procedures.
Following the three (3) day monitoring period, I 
understand I will then be asked to return my forms, 
glucometer, and urine samples to the experimenter. I also 
will be asked to complete a questionnaire at that time. 
Before I leave I will be paid and the results of the study 
explained to me.
I understand that any information about me obtained 
as a result of my participation in this research will be 
kept as confidential as legally possible. I understand I 
will be identified by number only. However, I also 
understand that my research records, like hospital 
records, can be subpoenaed by court order or may be 
inspected by federal regulatory authorities.
To the best of my knowledge I am not suffering from 
any impairment or disease that might interfere with this 
project. When I return to the laboratory for the 
completion of the study, I will receive a monetary 
compensation of $5.00 for each day of home monitoring I 
completed if I complete all three days of monitoring.
There are no direct benefits to me other than the monetary 
compensation. Although there are minimal risks associated 
with my participation in this study, I understand some 
risks may be unforeseeable. Should injury occur as a 
result of this research, voluntary compensation is not 
provided. There are no costs or special fees for 
participating.
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In signing this consent form, I state that I have 
read and understand the description of the monitoring and 
questionnaires. Any questions I have had have been 
answered to my satisfaction. I understand if I have any 
questions about my rights as a research participant I can 
contact the Institutional Review Board for the Protection 
of Human Subjects at (304) 293-7073.
I enter into this research willingly as a volunteer 
and may withdraw at any time without fear of retribution. 
Refusal to participate involves no retribution or penalty 
or loss of benefit to which I am entitled. I will be 
given a copy of the consent form. If I have any further 










DAY #: _1__ DATE: ____________
Please write down everything you eat or drink from the 
time you get up until you go to bed. Include drinks of 
all kinds. Specify the AMOUNT, HOW IT WAS PREPARED, AND 
ANYTHING THAT IS ADDED such as butter, margarine, fat, 
oil, salad dressing, sugar, syrup, etc.
TIME FOOD DESCRIPTION AMOUNT
APPENDIX D 
Insulin and Blood Glucose Log
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BLOOD GLUCOSE LOG 
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Below are listed a brief series of questions 
regarding treatment recommendations made for your care by 
your physician. Please indicate to the best of your 
knowledge what your physician asked your to do in each of 
the three areas below:
EXERCISE
  1. My physician recommended I exercise.
  2. How frequently did your physician suggest you
exercise?
______  Weekly
______  Twice per week
______  Three times per week
______  More than 3 times per week
  3. How long did your physician suggest you exercise
during each exercise period?
______  Less than 10 minutes
______  1 0 - 1 9  minutes
______  2 0 minutes
______  more than 20 minutes
  4. My physician DID NOT recommend I exercise as part
of my prescribed treatment.INSULIN USE
Please indicate amount, type, and timing of insulin 
injections prescribed for you.
TYPE_______________ AMOUNT______________________TIME_______
DIETARY RECOMMENDATIONS
Please indicate the dietary recommendations prescribed for 
you.
__________  calorie ADA diet
__________  other, please explain:
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